Robert F. Jacob

4.6k total citations
74 papers, 3.8k citations indexed

About

Robert F. Jacob is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Robert F. Jacob has authored 74 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Physiology and 18 papers in Surgery. Recurrent topics in Robert F. Jacob's work include Nitric Oxide and Endothelin Effects (15 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Lipoproteins and Cardiovascular Health (10 papers). Robert F. Jacob is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Antioxidant Activity and Oxidative Stress (12 papers) and Lipoproteins and Cardiovascular Health (10 papers). Robert F. Jacob collaborates with scholars based in United States, Argentina and Austria. Robert F. Jacob's co-authors include Ronald P. Mason, Mary Walter, William E. Klunk, R. Preston Mason, Tadeusz Maliñski, Charles Day, Yoshiko Mizuno, Samuel Sherratt, Richard J. Cenedella and Samuel F. Lockwood and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Robert F. Jacob

74 papers receiving 3.7k citations

Peers

Robert F. Jacob
Robert F. Jacob
Citations per year, relative to Robert F. Jacob Robert F. Jacob (= 1×) peers Constantinos A. Demopoulos

Countries citing papers authored by Robert F. Jacob

Since Specialization
Citations

This map shows the geographic impact of Robert F. Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Jacob more than expected).

Fields of papers citing papers by Robert F. Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Jacob. The network helps show where Robert F. Jacob may publish in the future.

Co-authorship network of co-authors of Robert F. Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Jacob. A scholar is included among the top collaborators of Robert F. Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Jacob. Robert F. Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mason, R. Preston, et al.. (2016). EICOSAPENTAENOIC ACID AND ATORVASTATIN ACTIVE METABOLITE, ALONE OR IN COMBINATION, REVERSED GLUCOSE- AND OXIDIZED LDL-INDUCED ENDOTHELIAL DYSFUNCTION MEASURED EX VIVO IN RATS. Journal of the American College of Cardiology. 67(13). 2320–2320. 3 indexed citations
2.
Mason, Ronald P., et al.. (2016). AMLODIPINE INCREASES NITRIC OXIDE RELEASE IN ENDOTHELIAL CELLS COLLECTED FROM DONORS OF DIFFERENT RACES AND ENOS GENE VARIANTS. Journal of the American College of Cardiology. 67(13). 2321–2321. 2 indexed citations
3.
Mason, R. Preston & Robert F. Jacob. (2014). Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(2). 502–509. 59 indexed citations
4.
Mason, Ronald P. & Robert F. Jacob. (2014). Characterization of Cholesterol Crystalline Domains in Model and Biological Membranes Using X-Ray Diffraction. Advances in experimental medicine and biology. 842. 231–245. 1 indexed citations
5.
Jacob, Robert F., et al.. (2013). Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density Lipoprotein. Journal of Cardiovascular Pharmacology. 62(2). 160–166. 11 indexed citations
6.
Mason, Ronald P., Robert F. Jacob, Ruslan Kubant, et al.. (2011). Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese Rats. Journal of Atherosclerosis and Thrombosis. 18(9). 774–783. 55 indexed citations
7.
Jacob, Robert F., et al.. (2011). DRONEDARONE ENHANCES RAT AORTIC AND GLOMERULAR ENDOTHELIAL NITRIC OXIDE RELEASE IN A DOSE-DEPENDENT MANNER. Journal of the American College of Cardiology. 57(14). E1431–E1431. 2 indexed citations
8.
Jacob, Robert F., et al.. (2009). Glucose promotes membrane cholesterol crystalline domain formation by lipid peroxidation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1788(6). 1398–1403. 27 indexed citations
9.
Walter, Mary, Robert F. Jacob, Barrett Jeffers, et al.. (2008). Circulating Lipid Hydroperoxides Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology. 51(12). 1196–1202. 49 indexed citations
10.
Mason, Ronald P., Mary Walter, Charles Day, & Robert F. Jacob. (2006). Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism. Journal of Biological Chemistry. 281(14). 9337–9345. 69 indexed citations
11.
Mason, Ronald P., Leszek Kalinowski, Robert F. Jacob, Adam Jacoby, & Tadeusz Maliñski. (2005). Nebivolol Reduces Nitroxidative Stress and Restores Nitric Oxide Bioavailability in Endothelium of Black Americans. Circulation. 112(24). 3795–3801. 153 indexed citations
12.
Jacob, Robert F., Charles Day, Ronald P. Mason, & Richard J. Cenedella. (2005). Biochemical and Structural Characterization of Lipid Raft–Like Fractions Isolated From Bovine Lens Cortical Membrane by Octyl Glucoside Extraction. Investigative Ophthalmology & Visual Science. 46(13). 1864–1864. 1 indexed citations
13.
Walter, Mary, et al.. (2004). 882-4 Active hydroxy metabolite of atorvastatin increases resistance of human low-density lipoproteins to oxidative modification. Journal of the American College of Cardiology. 43(5). A529–A529. 4 indexed citations
14.
Walter, Mary, Robert F. Jacob, Barrett Jeffers, et al.. (2004). Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease. Journal of the American College of Cardiology. 44(10). 1996–2002. 167 indexed citations
15.
Mason, Ronald P., Thomas N. Tulenko, & Robert F. Jacob. (2003). Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiology. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1610(2). 198–207. 98 indexed citations
16.
Mason, Ronald P., et al.. (2000). Antioxidant activity of the monoamine oxidase B inhibitor lazabemide. Biochemical Pharmacology. 60(5). 709–716. 15 indexed citations
17.
Klunk, William E., Robert F. Jacob, & Ronald P. Mason. (1999). [19] Quantifying amyloid by congo red spectral shift assay. Methods in enzymology on CD-ROM/Methods in enzymology. 309. 285–305. 305 indexed citations
18.
Mason, Ronald P., Peter Leeds, Robert F. Jacob, et al.. (1999). Inhibition of Excessive Neuronal Apoptosis by the Calcium Antagonist Amlodipine and Antioxidants in Cerebellar Granule Cells. Journal of Neurochemistry. 72(4). 1448–1456. 97 indexed citations
19.
Klunk, William E., Robert F. Jacob, & Ronald P. Mason. (1999). Quantifying Amyloid β-Peptide (Aβ) Aggregation Using the Congo Red-Aβ (CR–Aβ) Spectrophotometric Assay. Analytical Biochemistry. 266(1). 66–76. 264 indexed citations
20.
Robbins, K. Thomas, Julia Bowman, & Robert F. Jacob. (1987). Postglossectomy Deglutitory and Articulatory Rehabilitation With Palatal Augmentation Prostheses. Archives of Otolaryngology - Head and Neck Surgery. 113(11). 1214–1218. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026